Ipamorelin vs GHRP-6 half-life

Ipamorelin has an elimination half-life of about 2 h; GHRP-6 has about 30 min. Both are ghrelin-receptor agonists. GHRP-6 is an older peptide known for strongly increasing appetite, while ipamorelin is more selective for growth hormone release.

Side by side

IpamorelinGHRP-6
Half-life2 h30 min (range 15 min–1 h)
RouteSC / IVSC
CategoryGH secretagoguesGH secretagogues
EvidenceLimitedLimited
Remaining after 24 hours0.02%<0.01%
Remaining after 7 days<0.01%<0.01%
~97% cleared (5 half-lives)10 h2.5 h
Steady state (4-5 half-lives)8 h to 10 h2 h to 2.5 h

Single-dose decay

Share of one dose remaining over time, assuming first-order elimination. Dashed lines mark each half-life.

Ipamorelin vs GHRP-6 single-dose decay 0% 25% 50% 75% 100% 0 2 h 4 h 6 h 8 h 10 h

Ipamorelin (t½ 2 h) GHRP-6 (t½ 30 min)

Ipamorelin: Human IV PK study: terminal half-life about 2 hours. GHRP-6: Sparse human PK; short plasma half-life.

Model Ipamorelin doses Model GHRP-6 doses

FAQ

Which lasts longer, Ipamorelin or GHRP-6?

Ipamorelin lasts longer. Its half-life is about 2 h, versus 30 min for GHRP-6, roughly 4 times longer.

How long do Ipamorelin and GHRP-6 stay in your system?

With first-order elimination, about 97% of a single dose is cleared after five half-lives: roughly 10 h for Ipamorelin and 2.5 h for GHRP-6. Individual clearance varies.

How long until Ipamorelin and GHRP-6 reach steady state?

With consistent repeated dosing, levels approach steady state after 4 to 5 half-lives: about 8 h to 10 h for Ipamorelin, and 2 h to 2.5 h for GHRP-6.

How reliable are these half-lives?

Ipamorelin: Limited evidence. GHRP-6: Limited evidence. Anecdotal values are community estimates and may be far off.

Related comparisons